Original articleParental Attitudes and Beliefs Regarding the Nine-Valent Human Papillomavirus Vaccine
Section snippets
Methods
Online focus groups were conducted in January, 2015, with a U.S. national convenience sample of parents. A total of four focus groups were convened: two groups of parents of HPV unvaccinated daughters aged 9–12 years and two groups of parents of fully vaccinated daughters aged 11–17 years. This study focused on female vaccination as parental beliefs on vaccination may differ based on a child's sex; subsequent work should include parents of males. In addition, HPV9 has greater potential benefit
Demographic characteristics
The final sample consisted of 81 parents of 97 daughters. Forty-three were parents of fully vaccinated (three-dose completion) daughters; 38 were parents of unvaccinated daughters. The parents were diverse, representing 31 states and all nine U.S. Census regions [11]. The majorities of parents were female, had completed some college or obtained a college degree, were employed full time, and were married. See Table 2 for sociodemographic information on parents and daughters.
Qualitative analysis
Four main categories
Discussion
Consistent with other research on HPV vaccination, we found that most parents see HCP recommendation as among the most important factors in deciding about vaccination [12], [13], [14]. Parents clearly valued HCP expertise and expected their daughters' providers to be well informed about HPV9 and to be able to answer any questions that arise. It was notable, however, that there remained substantial gaps in knowledge and misunderstanding about the reasons for the recommendation to vaccinate all
Funding Sources
Support for this study was provided by Indiana University-Purdue University Center for HPV Research, which is funded by the Indiana University-Purdue University Signature Centers Initiative and the support of the IU School of Medicine, Department of Pediatrics and the IU Simon Cancer Center, and Boston College Internal Start-up Funds awarded to Dr. Fontenot.
References (19)
- et al.
Qualitative content analysis in nursing research: Concepts, procedures, and measures to achieve trustworthiness
Nurse Educ Today
(2004) - et al.
Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons
Vaccine
(2014) - et al.
The defining characteristics of Web 2.0 and their potential influence in the online vaccination debate
Vaccine
(2012) - et al.
Sorting through search results: A content analysis of HPV vaccine information online
Vaccine
(2012) - Centers for Disease Control and Prevention. Human papillomavirus (HPV). 2013. Available at:...
- U.S. Food and Drug Administration. June 8, 2006 Approval letter-human papillomavirus quadrivalent (types 6, 11, 16, 18)...
- U.S. Food and Drug Administration. October 16, 2009 Approval letter-Gardasil. Available at:...
FDA licensure of bivalent human papillomavirus vaccine (HPV2, cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee of Immunization Practices (ACIP)
MMWR Morb Mortal Wkly Rep
(2010)- U.S. Food and Drug Administration. News & events: FDA approves Gardasil 9 for prevention of certain cancers caused by...